Company / Assets per Share
CUMBERLAND PHARMACEUTICALS INC Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$5.51
FY2025
5-year range
$5.35 / $6.30
FY2021-FY2025
Trend
+2.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share returned to growth in FY2025 after 2 years of decline, reaching $5.51.
Based on SEC 10-K filings.
5.51 in FY2025 with a 5-year CAGR of -2.7%.
Declined from $5.69 to $5.51 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -4.4%
- 5-Year CAGR
- -2.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share increased 2.9% year-over-year.
- Peak assets per share was recorded in FY2018.
- Lowest assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.51 | +2.9% |
| FY2024 | $5.35 | -6.0% |
| FY2023 | $5.69 | -9.7% |
| FY2022 | $6.30 | +11.9% |
| FY2021 | $5.64 | -10.8% |
| FY2020 | $6.32 | -6.4% |
| FY2019 | $6.75 | -3.7% |
| FY2018 | $7.01 | +20.9% |
| FY2017 | $5.80 | +1.7% |
| FY2016 | $5.70 | +6.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026